Project Grant R21DA060455
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $198K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- This Project Grant award of $126,660 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research at the University of California, San Diego (UCSD) to investigate the role of tandem repeats and structural variants in addiction-related behaviors using heterogeneous stock rats. The key objectives are to: 1) characterize the landscape of tandem repeats and structural variants in heterogeneous stock rats using long-read...
- This Project Grant award of $149,804 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to identify new genetic regulators that influence opioid signaling pathways. The goal is to expand understanding of the opioid signaling landscape and identify potential genetic targets to tune signaling biases for safer and more effective opioid treatments. The University of Florida is the awardee and will implement a MOR-MAPK...
- This federal Project Grant award of $272,395.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to develop methods for targeting the G9A and GLP enzymes, which are involved in the development of addictive behaviors to stimulants and opioids. The research aims to better understand the molecular functions of G9A and GLP in the addiction process and explore therapeutic approaches that do not rely on catalytic site...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $715,238 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of California, San Diego (UCSD) to conduct a "Multivariate Genome-Wide Association Analysis of Opioid-Related Traits in Half a Million Diverse Individuals." The project aims to improve understanding of the genetic basis of opioid use disorder (OUD) and related pre-addiction...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, is funded through the Drug Use and Addiction Research Programs (CFDA 93.279). The $454,251 award will support the development of a new approach for long-term monitoring of opioid-induced changes in neural population activity and opioid receptor gene expression in mice exposed to fentanyl. Specifically, the project aims to create "erasable"...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a forward genetic screen to identify novel genes involved in the mechanism of action of the addictive psychostimulant amphetamine (AMPH). The $571,675 award to Florida Atlantic University will fund research using mutated strains from the Million Mutations Project to screen for AMPH-induced behaviors and select animals with altered responses to...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $707,108 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Regents of the University of California, Berkeley (UC Berkeley) for the "International Development Project (IDP): An International Collaboration for the Standardized Study of Experience-Dependent Brain and Behavioral Development". The project aims to study the effects of various forms of...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund research to investigate the role of cholinergic interneurons in the ventral tegmental area on opioid-related behaviors. The $373,181 grant, awarded on July 15, 2024 with a completion date of June 30, 2027, aims to determine whether mu-opioid receptors on cholinergic interneurons contribute to opioid reward, consumption, and withdrawal, and how...
- This $480,000 Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop new tools to facilitate the study of how drugs of abuse interact with G protein-coupled receptors (GPCRs) and alter their signaling. The key products and services to be delivered under this 5-year grant include: Generation of chemical biology tools to enable time-resolved cryogenic electron microscopy imaging of GPCR...
- This federal Project Grant award for $357,613 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to leverage large-scale whole-genome sequencing (WGS) data to identify novel rare and common genetic variants associated with substance use disorders (SUDs). The project, awarded to Yale University, has two key objectives: 1) to recover missing heritability in SUDs by analyzing WGS data from biobanks, and 2) to develop a novel...